Clinical trials
Active, not recruiting Phase 3 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 10 |
| Eli Lilly and Company | 3 |
| UNICANCER | 3 |
| M.D. Anderson Cancer Center | 2 |
| NRG Oncology | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Celcuity Inc | 1 |
| David Palma | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GT Medical Technologies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 31 |
| Breast Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 4 |
| Brain Neoplasms | 3 |
| Breast Diseases | 3 |
| Carcinoma | 3 |
| Prostatic Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.